Two implanted heart devices used by patients in end-stage heart failure are now under a strict U.S. Food and Drug ...
The recall comes years after surgeons say they first noticed problems with the HeartMate II and HeartMate 3, manufactured by ...
The recall affects the only medical option for many patients with end-stage heart failure who do not qualify for a transplant ...
The FDA calls this "the most serious type of recall," alerting healthcare providers as well as patients about these products ...
The FDA announced Monday that two heart pump products are being recalled after reports of 14 deaths and hundreds of injuries ...
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's device used to block blood flow ...
The Food and Drug Administration (FDA) recently announced that two heart devices, the HeartMate II and HeartMate 3 Left ...
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of ...
People should rely on the well-established Heimlich maneuver to save a choking victim, rather than newfangled "anti-choking" ...
Biological material can build up and obstruct blood flow in heart failure patients supported by the left ventricular assist devices, the FDA said.
Stifel Nicolaus analyst Rick Wise has maintained their bullish stance on BSX stock, giving a Buy rating today. Rick Wise’s rating is based on a comprehensive evaluation of Boston Scientific’s recent ...
Good day, and thank you for standing by. Welcome to GE Healthcare's First Quarter 2024 Earnings Conference Call. (Operator Instructions) Please note that today's conference may be recorded. I will now ...